KOPRAN
Back to Income Statement
|
KOPRAN Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹26 Cr | ₹39 Cr | ₹51 Cr | ₹27 Cr | ₹61 Cr |
What is the latest Consolidated Net Profit of KOPRAN ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹26 Cr |
| Mar2025 | ₹39 Cr |
| Mar2024 | ₹51 Cr |
| Mar2023 | ₹27 Cr |
| Mar2022 | ₹61 Cr |
How is Consolidated Net Profit of KOPRAN Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹26 Cr | -33.26 | |
| Mar2025 | ₹39 Cr | -24.34 | |
| Mar2024 | ₹51 Cr | 87.11 | |
| Mar2023 | ₹27 Cr | -55.38 | |
| Mar2022 | ₹61 Cr | - | |
Compare Consolidated Net Profit of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹926.6 Cr | -5% | 2.6% | 5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,993.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | -5% |
2.6% |
5% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses